We describe an approach for formulating criteria that can be used to judge whether an analytical method has acceptable precision and accuracy. We derive criteria for several experiments that are commonly used in method-evaluation studies: precision or replicates, recovery, interference, and comparison of patient values between the new method and a proven method. These criteria are based on the medical usefulness of the test results, thus the acceptability of the method is judged with respect to the clinical requirements. elapsed time between specimen submission and report of results, and precisionand accuracy. The analyst, or clinical chemist, must confer with the physician to obtain an adequate definition of these medical requirements. In addition, he must define other requirements based on the technical and economic resources of the laboratory.
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In setting up the analytical method, the analyst must optimize the method to best satisfy all of the requirements.
He may develop a new method, or he may evaluate existing methods that appear to satisfy all of the requirements.. In developing a method, he will strive to satisfy the physical requirements such as the amount of specimen, range of linearity, etc., and then evaluate the performance of the method. At this early stage of testing or developmental testing, he relies primarily on simple experiments for determination of within-run precision, recoyery, and interference. When they indicate that the method appears to be acceptable, a final stage of testing (method evaluation) is conducted that includes experiments for determination of run-to-run precision and comparison of values obtained for patients with the test method and a reference method. Regardless of which experiments are used, the analyst's objectives are to quantify precision and accuracy; hence to judge whether the method performs acceptably, the analyst must have objective criteria for judging precision and accuracy.
Formulation of Criteria for Judging Precision and Accuracy
To the analyst, precision means random analytic error. This is illustrated in Figure 1 by the distribution of the individual measurements around a mean value. Accuracy, on the other hand, is commonly thought to mean systematic analytic error, which is shown in Figure 1 by the difference between the mean of the measured values and the "true" value. Analysts sometimes find it useful to divide this systematic error into constant and proportional compo- familiar to the physician who uses the test values, therefore he isseldom ableto communicate with the analyst in these terms. The physician thinks rather in terms of the total analytical error, which includes both random and systematic components.
From his point of view, all types of analytic error are acceptable as long as the total analytic error is less than a specified amount. This total analytic error is illustrated as the second definition of accuracy in Figure   1 . This definition is medically more useful; after all, it makes little difference to the patient whether a laboratory value is in error because of random or systematic analytic error, and ultimately he is the one who must live with the error. Because the medical requirements for performance can best and most easily be described in terms of the total analytic error, we formulate standards for acceptable performance by using this concept of total error. To do this, a specified value for the total allowable error is interpreted as a 95% limit2 of allowable error (EA).3 In addition to EA, it is necessary to specify the medical decision level (Xc), the concen- data not sufficient for a judgment on performance recognize that class c methods are likely to be borderline in terms of performance. Acceptance of such a method will undoubtedly require more stringent quality control and attention from the analyst in order to maintain an adequate performance when the method is in routine service.
By using this approach, we have formulated criteria that are applicable to several different evaluation experiments. Random analytic error (RE) is estimated from the replicate or precision experiment, proportional systematic analytic error (PE) from the recovery experiment, constant systematic analytic error (CE) from the interference experiment, mean systematic analytic error (SE, includes both PE and CE) from the patient comparison experiment, and finally total analytic error (TE) from the experiments on replicates and patient comparisons. Table 1 summarizes the analytic errors, the experiments from which they are estimated, and the performance criteria. Appendix 1 gives a detailed discussion of the formulation of the criteria and Appendix 2 gives examples of the application of the criteria.
Discussion
The concept of total analytic error that is presented here is not new. Eisenhart (11) discussed this many years ago, and the ASTM standard on precision and accuracy (12) recommends that accuracy be documented by use of two terms-one that estimates random analytic error and the other systematic analytic error (or precision and bias, in their terminology). The manner in which these terms are combined here is different, but it is consistent with the medical use of the laboratory data and therefore appropriate for the problem with which we are concerned.
Of the five error criteria that we have derived, the TE criterion is the most demanding because it includes both RE and SE. The other criteria consider individual analytic errors and each could be judged as acceptable, even when the total analytic error is not acceptable. This is readily apparent when RE and SE individually approach EA, since TE will be nearly twice EA when RE and SE are summed. Thus the criterion for TE is often sufficient by itself for judging the acceptability of performance. The other criteria are most useful in the early stages of method development and testing. During this time, TE could be approximated by summation of the individual
In applying the proposed criteria, the conclusions on performance depend on the definition of performance standards (PS). When initially attempting to define PS, the analyst can be guided by the recommendations of Barnett (13) , Campbell and Owen (14) , Tonks (15) , Cotlove et. al. (16) , Vanko (17) , and Duncan and Geary (18) . These authors present recommendations for maximum allowable SD's that should be multiplied by 2 to provide a 95% limit for allowable analytic error. Barnett's recommendations most closely represent the medically allowable error, since they are based on medical judgment and include the medical decision levels. Campbell and Owen surveyed physicians for recommendations for "acceptable reproducibility," but their data are more limited than Barnett's. Tonk's and Cotlove's limits are dependent on the range of variation in normal subjects and are more theoretically defined. Vanko summarizes "state of the art" performance limits, that is, the performance that is available from methods that are in use today. "State of the art" information is also available through state and nation- 
Total (TE) Replicate and comparison 95% confidence limits (SD1 and SD11, resp.) are calculated as described by Natrella (7) and shown in equations 1 and 2, SDTU = SDT (upper factor)
where the upper and lower factors are listed in Table  2 as a function of degrees of freedom, which is N-i, where N is the number of replicates. The 95% upper limit for random analytic error (REd) is given by equation 3 and the 95% lower limit (RE1) by equation4:
RE by itself is acceptable when
2SDTU < E
RE by itself is not acceptable when
Example Calculation:
We illustrate the calculations for a glucose method and refer back to our earlier definition of performance standards, PS1 = 10 mg/dl at 50 mg/dl and PS2 = 10 mg/dl at 120 mg/dl. For an observed SD1 of 2.0 mg/dl, which was obtained from 21 measurements on a pool which averaged 55 mg/dl, SD lu is 2.7 mg/dl (2.0 X 1.358) and RE is 5.4 mg/dl (2 X 2.7). For an observed SD1 of 3.0 mg/dl at 110 mg/dl (N = 21), SD1 is 4.1 mg/dl and RE is 8.2 mg/dl. For both decision levels, the upper limit of random analytic error is less than the medically allowable error, therefore RE by itself is acceptable. 
where t is obtained from a statistics table for P = 0.05 and N-i degrees of freedom, and SEM is the standard error of the mean recovery. 
but is not acceptable when
Example Calculation: is 98.0% for nine experiments, the standard deviation of the recoveries is 1.5%. SEM is L5%/v'9, or 0.5%. if the method is to be used for screening purposes, a concentration of inter- (8) fering material that corresponds to the upper limit of variation in normal subjects may be acceptable. If the method is to be used for hospitalized patients, the concentration added should represent the upper limit of concentration expected in these patients.
The experiment is commonly performed in two different ways. The original sample and the interference sample can be analyzed in replicate, or a series (9) of samples can be analyzed singly. The experimental data can be analyzed with t-test statistics, using 4The standard error of the mean (SEM) is equal to SD/v"N where SD is the standard deviation of the individual observations and N is the number of observations.
The imprecision of the method is judged separately in the RE criteria (equations 5 and 6); however, there is still an uncertainty in the estimate of a systematic analytic error caused by the imprecision. This uncertainty can be made small by having a sufficiently large number of ob- (12) servations.
"unpaired" and "paired" forms for the multiple and singlesample experiments,respectively. The mean CE is estimated by bias3 and upper and lower limits can be calculated from SDd,3 N, and the appropriate t-value forP = 0.05 and N-i degrees of freedom. (1) by both the test and reference methods. We assume the case where an accurate reference method is available, therefore differences between the test and reference methods are due to errors that originate in the test method.5 The statistical approach must be appropriate for the experimental situation; however, some form of leastsquares analysis will generally be applicable, sometimes simple linear regression, or more generally "confluence" analysis6 (8, 9) . We illustrate the formulation of criteria for the simple case when linear regression can be used, i.e., the case when random analytic error in the reference method (X value) is sufficiently small that unbiased estimates of the slope and intercept are obtained. For confluence analysis, the equations are similar, but more complicated. For simple linear regression, the 95% limits of systematic analytic error are estimated as described by Natrella (10) . The average testvalue (Yc) that cor- (15) responds to the critical medical concentration (Xc) is calculated from the regression equation.
Y=a+bX (19)
The 95% limits for Yc are given by equations 20 and 21.
51n practice, the selection of a reference method is indeed a problem, but for many commonly measured substances, such as glucose, calcium, etc., there are methods that are generally accepted (by consensus) as being accurate enough for this purpose. Differences between test and reference values are still assumed to be errors in the test method, unless proven otherwise. Enzyme methods, hormone assays, and many other newly developed tests do not fit this experimental model and will have to be approached in a somewhat different manner. 6 Confluence analysis is used here to designate a least-squares technique that allows for random error in both x and y. Simple linear regression allows for error only in y and may give an estimate for the slope that is too low and an estimate for the intercept that is too high. (a + bXc) -Xc! + ISDTU) At both decision levels, the upper limits of systematic error are less than EA, thus systematic error by itself is small enough for the method to be acceptable.
Total analytic error (TE). The random and systematic components must be considered together, to estimate their total effect. On the average, the analytic error is simply the systematic error. But for a single measurement on a patient sample, the actual error may range above or below the mean value by an amount that depends on the total uncertainty. This uncertainty includes both the uncertainty in the estimateof systematicerrorand the uncertainty of a single measurement (i.e., the random analytic error of the method). 
Appendix 2. Example Applications
In this section we illustrate the application of the TE criteria to some glucose studies that are typical of those appearing in the recent literature.
In judging the performance of these methods, we consider two performance standards (PS1 = 10 mg/dl at 50 mg/ dl, PS2 = 10 mg/dl at 120 mg/dl). The statistical summary of the experimental data is given in Part A of These three examples point out the difficulty in applying the criteria to published evaluationdata. Approximations are usually necessary because the statistical data are not complete. However, even with approximation, the judgments on performance are likely to be much more objective than the judgments made without the aid of these criteria.
